Agios PharmaceuticalsvsAmgen

AGIO and AMGN stock compared: price, dividend, valuation and results, from SEC filings.

AGIO

Agios Pharmaceuticals, Inc.

$29.68

Value $1.7B

-0.70%
AGIO's page

AMGN

Amgen Inc.

$443.89

Value $239B

-3.07%
AMGN's page

Agios Pharmaceuticals (AGIO) has a market value of $1.7B and Amgen (AMGN) $239B. Over the last year, with dividends, AGIO moved -34.2% and AMGN +33.5%. Dividend yield: AGIO none, AMGN 2.24%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AGIO$1.7B

    AMGN$239B

    AMGN is 138 times AGIO

  • Revenue, 12 months

    AGIO$141M

    AMGN$38.9B

    AMGN is 276 times AGIO

  • Net income, 12 months

    AGIO-$373M

    AMGN$9.4B

  • Operating margin

    AGIO-297.7%

    AMGN32.4%

    330.1 points apart

  • ROIC

    AGIO-29.6%

    AMGN16.2%

    45.8 points apart

  • P/E

    AGIO–

    AMGN25.5

  • Dividend yield

    AGIO0.0%

    AMGN2.2%

    2.2 points apart

  • 5-year return

    AGIO-25.2%

    AMGN+149.9%

    175.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AGIO-25.2%

AMGN+149.9%

10020020222023202420252026
Returns by period
PeriodAGIOWith dividendsAMGNWith dividends
1 year since November 17, 2025-34.2%Price -34.2%+33.5%Price +29.9%
3 years since November 17, 2023+33.3%+10.1% a yearPrice +33.3%+81.6%+22.0% a yearPrice +67.3%
5 years since November 17, 2021-25.2%-5.6% a yearPrice -25.2%+149.9%+20.1% a yearPrice +115.7%
10 years since November 18, 2016-52.5%-7.2% a yearPrice -52.5%+308.8%+15.1% a yearPrice +205.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AGIOAgios PharmaceuticalsAMGNAmgen

Valuation

AGIOAMGN
Valuation
Price$29.68$443.89
Market value$1.7B$239B
Enterprise value (EV)$832M$280B
P/E–25.5
P/E, 5-year median–23.0
P/B1.816.7
EV/EBIT–22.2
Free cash flow yield–4.0%

Results and growth

AGIOAMGN
Results and growth
Revenue, 12 months$141M$38.9B
Net income, 12 months-$373M$9.4B
Free cash flow, 12 months-$336M$9.6B
Earnings per share, 12 months-$6.32$17.25
Revenue growth, year on year48.0%10.0%
Revenue growth a year, past–+7.6%over 5 years
EPS growth a year, past–+2.9%over 5 years

Margins and returns on capital

AGIOAMGN
Margins and returns on capital
Gross margin93.8%70.9%
Operating margin-297.7%32.4%
Net margin-264.8%24.1%
ROIC-29.6%16.2%
ROE-33.3%87.8%

Balance sheet

AGIOAMGN
Balance sheet
Cash$907M$13.2B
Total debt$27M$54.0B
Net debt / EBITDA–2.3
Interest cover–4.8×

Dividends and buybacks

AGIOAMGN
Dividends and buybacks
Dividend yield–2.2%
Dividend per share, 12 months–$9.94
Dividend growth a year, past–+8.1%over 5 years
Buyback yield––
Shareholder yield–2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AGIO or AMGN

Didn't find what you were looking for?

Ask us
Which is bigger, Agios Pharmaceuticals or Amgen?

By market value, Amgen ($239B) is about 137.6 times Agios Pharmaceuticals ($1.7B), at today's prices.

How did AGIO and AMGN stock do over the last 10 years?

Since November 18, 2016, AGIO's price moved -52.5% and AMGN's +205.6%. With dividends: AGIO -52.5% (-7.2% a year), AMGN +308.8% (+15.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AGIO or AMGN?

The dividend yield at today's price is none for Agios Pharmaceuticals and 2.24% for Amgen. Over the last twelve months they paid – and $9.94 per share.

Which has the higher profit margins, Agios Pharmaceuticals or Amgen?

Over the last twelve months, the net margin was -264.8% for Agios Pharmaceuticals and 24.1% for Amgen, and the operating margin -297.7% and 32.4%. Revenue was $141M and $38.9B.

Which is the better investment, Agios Pharmaceuticals or Amgen?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.